Overall, 2018 showed favorable trends for opioid use with declines in both utilization and cost. Understanding the top opioid medications being filled and impacting spend can help guide decision-making and aid in identifying opportunities for intervention particularly through formulary controls, utilization management strategies, and through insight into regulatory changes and juris-specific rule application. Watch the video blog to learn more.
On average 39% of pharmacy spend comes from non-network dispensing channels.
At Genex, we've always been passionate about advancing the field of case management.
In this WCI-TV interview, Brian Allen, VP of Governmental Affairs, offers an update on top regulatory and legislative initiatives that could impact
In this WCI-TV interview, Enlyte’s Tammy Bradly, Senior Director, Clinical Product Marketing, shares why states are implementing new workers’ comp
